Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
EDIT, CLNE and NIU Are Among After Hour Movers
Bluebird Bio Faces Nasdaq Compliance Challenge and Delays
Bluebird Bio Receives Non-compliance Notice From Nasdaq
$100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs
Vertex Pharmaceuticals Inc's (NASDAQ:VRTX) blockbuster drug Trikafta for cystic fibrosis (CF) has shown remarkable efficacy, potentially extending the lives of some patients by up to 45 years. Despite
HC Wainwright & Co. Reiterates Buy on Apellis Pharmaceuticals, Maintains $92 Price Target
HC Wainwright & Co. analyst Douglas Tsao reiterates Apellis Pharmaceuticals with a Buy and maintains $92 price target.
Vertex Announces European Commission Approval For Kalydeco To Treat Infants With Cystic Fibrosis Ages 1 Month And Older
Vertex Announces European Commission Approval For Kalydeco To Treat Infants With Cystic Fibrosis Ages 1 Month And Older